Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 08, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Desipramine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg.".